TrialScientific reports2023
Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients.
Jens Peter Klussmann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papertrialcites it